[Cytochemical, immunologic and gene rearrangement studies in adult acute leukemia]

Area of Science:

• Hematology
• Immunology
• Oncology

Context:

• Adult acute leukemias present diagnostic challenges.
• Morphological, cytochemical, and immunological methods are employed for classification.
• Distinguishing between acute myeloid leukemia (AML) and acute lymphoid leukemia (ALL) is critical for treatment.

Purpose:

• To compare the diagnostic utility of morphological, cytochemical, and immunological studies in adult acute leukemias.
• To evaluate the role of immunophenotyping with monoclonal antibodies in differentiating AML subtypes.
• To assess the importance of monoclonal antibodies and gene rearrangement studies in acute leukemia diagnosis and therapy.

Summary:

• Immunophenotyping with monoclonal antibodies is not effective for distinguishing AML subtypes but is essential for differentiating immature myeloid and lymphoid leukemias.
• Cytochemical methods remain valuable for clinical diagnosis of AML.
• Monoclonal antibodies are indispensable for diagnosing acute lymphoid leukemias (ALL) and guiding therapy, with gene rearrangement studies enhancing diagnostic accuracy for unclear cases.

Impact:

• Accurate diagnosis of acute leukemias is vital for appropriate and timely therapeutic interventions.
• The findings underscore the indispensable role of monoclonal antibodies in the routine diagnosis of ALL in hematological centers.
• Gene rearrangement studies offer improved accuracy, particularly for leukemias with indeterminate immunological origins, aiding in personalized treatment strategies.